Clinical trial
Phase II Study Of Single-Agent SU011248 In The Treatment Of Patients With Renal Cell Carcinoma
NCT00254540 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study Of Single-Agent SU011248 In The Treatment Of Patients With Renal Cell Carcinoma
- Lead sponsor
- Pfizer
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- February 28, 2009
- Enrollment
- 51 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.